BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33693553)

  • 1. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
    Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
    Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
    Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patients.
    Bailey JA; Morton AJ; Jones J; Chapman CJ; Oliver S; Morling JR; Patel H; Humes DJ; Banerjea A
    Colorectal Dis; 2024 Feb; 26(2):309-316. PubMed ID: 38173125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
    J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham.
    Chapman C; Thomas C; Morling J; Tangri A; Oliver S; Simpson JA; Humes DJ; Banerjea A
    Colorectal Dis; 2020 Jun; 22(6):679-688. PubMed ID: 31876975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
    Saw KS; Liu C; Xu W; Varghese C; Parry S; Bissett I
    Br J Surg; 2022 Feb; 109(2):182-190. PubMed ID: 34907419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
    Pin Vieito N; Zarraquiños S; Cubiella J
    World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
    Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J
    BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Gerrard AD; Maeda Y; Miller J; Gunn F; Theodoratou E; Noble C; Porteous L; Glancy S; MacLean P; Pattenden R; Dunlop MG; Din FVN;
    Br J Surg; 2023 Mar; 110(4):471-480. PubMed ID: 36785496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
    Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
    Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Service evaluation of faecal immunochemical testing introduced for use in North East London for patients at low risk of colorectal cancer.
    Ayling RM; Machesney M
    J Clin Pathol; 2021 Mar; 74(3):163-166. PubMed ID: 32646926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
    Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
    Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
    Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
    United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GP access to FIT increases the proportion of colorectal cancers detected on urgent pathways in symptomatic patients in Nottingham.
    Bailey JA; Khawaja A; Andrews H; Weller J; Chapman C; Morling JR; Oliver S; Castle S; Simpson JA; Humes DJ; Banerjea A
    Surgeon; 2021 Apr; 19(2):93-102. PubMed ID: 32327303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
    Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
    Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
    McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
    Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
    Tourne-Garcia C; Perez-Riquelme F; Monteagudo-Piqueras O; Fraser CG; Yepes-Garcia P
    J Med Screen; 2022 Dec; 29(4):231-240. PubMed ID: 35578555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.